Literature DB >> 27553952

Use of Causal Diagrams to Inform the Design and Interpretation of Observational Studies: An Example from the Study of Heart and Renal Protection (SHARP).

Natalie Staplin1, William G Herrington2, Parminder K Judge2,3, Christina A Reith2, Richard Haynes2,3, Martin J Landray2, Colin Baigent2,3, Jonathan Emberson2.   

Abstract

Observational studies often seek to estimate the causal relevance of an exposure to an outcome of interest. However, many possible biases can arise when estimating such relationships, in particular bias because of confounding. To control for confounding properly, careful consideration of the nature of the assumed relationships between the exposure, the outcome, and other characteristics is required. Causal diagrams provide a simple graphic means of displaying such relationships, describing the assumptions made, and allowing for the identification of a set of characteristics that should be taken into account (i.e., adjusted for) in any analysis. Furthermore, causal diagrams can be used to identify other possible sources of bias (such as selection bias), which if understood from the outset, can inform the planning of appropriate analyses. In this article, we review the basic theory of causal diagrams and describe some of the methods available to identify which characteristics need to be taken into account when estimating the total effect of an exposure on an outcome. In doing so, we review the concept of collider bias and show how it is inappropriate to adjust for characteristics that may be influenced, directly or indirectly, by both the exposure and the outcome of interest. A motivating example is taken from the Study of Heart and Renal Protection, in which the relevance of smoking to progression to ESRD is considered.
Copyright © 2017 by the American Society of Nephrology.

Entities:  

Keywords:  Bias (Epidemiology); Chronic; Epidemiology and outcomes; Kidney Failure; Motivation; Renal Insufficiency; Selection Bias; Smoking; causal diagrams; kidney; observational studies

Mesh:

Year:  2016        PMID: 27553952      PMCID: PMC5338700          DOI: 10.2215/CJN.02430316

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  23 in total

1.  Quantifying biases in causal models: classical confounding vs collider-stratification bias.

Authors:  Sander Greenland
Journal:  Epidemiology       Date:  2003-05       Impact factor: 4.822

2.  Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts.

Authors:  Ron T Gansevoort; Kunihiro Matsushita; Marije van der Velde; Brad C Astor; Mark Woodward; Andrew S Levey; Paul E de Jong; Josef Coresh
Journal:  Kidney Int       Date:  2011-02-02       Impact factor: 10.612

3.  Methods of covariate selection: directed acyclic graphs and the change-in-estimate procedure.

Authors:  Hsin-Yi Weng; Ya-Hui Hsueh; Locksley L McV Messam; Irva Hertz-Picciotto
Journal:  Am J Epidemiol       Date:  2009-04-10       Impact factor: 4.897

4.  Bias formulas for external adjustment and sensitivity analysis of unmeasured confounders.

Authors:  Onyebuchi A Arah; Yasutaka Chiba; Sander Greenland
Journal:  Ann Epidemiol       Date:  2008-08       Impact factor: 3.797

5.  Estimating causal effect with randomized controlled trial.

Authors:  Ian Shrier
Journal:  Epidemiology       Date:  2013-09       Impact factor: 4.822

6.  DAGitty: a graphical tool for analyzing causal diagrams.

Authors:  Johannes Textor; Juliane Hardt; Sven Knüppel
Journal:  Epidemiology       Date:  2011-09       Impact factor: 4.822

7.  Index event bias-a numerical example.

Authors:  Luc J M Smits; Sander M J van Kuijk; Pieter Leffers; Louis L Peeters; Martin H Prins; Simone J S Sep
Journal:  J Clin Epidemiol       Date:  2013-02       Impact factor: 6.437

8.  Relation between kidney function, proteinuria, and adverse outcomes.

Authors:  Brenda R Hemmelgarn; Braden J Manns; Anita Lloyd; Matthew T James; Scott Klarenbach; Robert R Quinn; Natasha Wiebe; Marcello Tonelli
Journal:  JAMA       Date:  2010-02-03       Impact factor: 56.272

9.  Combining directed acyclic graphs and the change-in-estimate procedure as a novel approach to adjustment-variable selection in epidemiology.

Authors:  David Evans; Basile Chaix; Thierry Lobbedez; Christian Verger; Antoine Flahault
Journal:  BMC Med Res Methodol       Date:  2012-10-11       Impact factor: 4.615

10.  Reducing bias through directed acyclic graphs.

Authors:  Ian Shrier; Robert W Platt
Journal:  BMC Med Res Methodol       Date:  2008-10-30       Impact factor: 4.615

View more
  20 in total

1.  Association of Urinary Oxalate Excretion With the Risk of Chronic Kidney Disease Progression.

Authors:  Sushrut S Waikar; Anand Srivastava; Ragnar Palsson; Tariq Shafi; Chi-Yuan Hsu; Kumar Sharma; James P Lash; Jing Chen; Jiang He; John Lieske; Dawei Xie; Xiaoming Zhang; Harold I Feldman; Gary C Curhan
Journal:  JAMA Intern Med       Date:  2019-04-01       Impact factor: 21.873

2.  Secondhand Smoke and CKD.

Authors:  Jong Hyun Jhee; Young Su Joo; Youn Kyung Kee; Su-Young Jung; Seohyun Park; Chang-Yun Yoon; Seung Hyeok Han; Tae-Hyun Yoo; Shin-Wook Kang; Jung Tak Park
Journal:  Clin J Am Soc Nephrol       Date:  2019-03-07       Impact factor: 8.237

3.  Racial and health insurance disparities in pediatric acute kidney injury in the USA.

Authors:  Erica C Bjornstad; Stephen W Marshall; Amy K Mottl; Keisha Gibson; Yvonne M Golightly; Anthony Charles; Emily W Gower
Journal:  Pediatr Nephrol       Date:  2020-01-29       Impact factor: 3.714

4.  Determinants and Outcomes Associated With Urinary Calcium Excretion in Chronic Kidney Disease.

Authors:  Jing Liu; Maria Clarissa Tio; Ashish Verma; Insa M Schmidt; Titilayo O Ilori; Felix Knauf; Finnian R Mc Causland; Sushrut S Waikar
Journal:  J Clin Endocrinol Metab       Date:  2022-01-01       Impact factor: 6.134

5.  Propensity Score and Instrumental Variable Techniques in Observational Transplantation Studies: An Overview and Worked Example Relating to Pre-Transplant Cardiac Screening.

Authors:  Ailish Nimmo; Nicholas Latimer; Gabriel C Oniscu; Rommel Ravanan; Dominic M Taylor; James Fotheringham
Journal:  Transpl Int       Date:  2022-06-27       Impact factor: 3.842

6.  Chronic Kidney Disease Is Associated With Greater Bone Marrow Adiposity.

Authors:  Gina N Woods; Susan K Ewing; Sigurdur Sigurdsson; Deborah M Kado; Joachim H Ix; Trisha F Hue; Gudny Eiriksdottir; Kaipin Xu; Vilmundur Gudnason; Thomas F Lang; Eric Vittinghoff; Tamara B Harris; Clifford J Rosen; Xiaojuan Li; Ann V Schwartz
Journal:  J Bone Miner Res       Date:  2018-08-27       Impact factor: 6.741

7.  Apolipoprotein B, Triglyceride-Rich Lipoproteins, and Risk of Cardiovascular Events in Persons with CKD.

Authors:  Julio Alejandro Lamprea-Montealegre; Natalie Staplin; William G Herrington; Richard Haynes; Jonathan Emberson; Colin Baigent; Ian H de Boer
Journal:  Clin J Am Soc Nephrol       Date:  2019-12-12       Impact factor: 8.237

8.  Evidence for Reverse Causality in the Association Between Blood Pressure and Cardiovascular Risk in Patients With Chronic Kidney Disease.

Authors:  William Herrington; Natalie Staplin; Parminder K Judge; Marion Mafham; Jonathan Emberson; Richard Haynes; David C Wheeler; Robert Walker; Charlie Tomson; Larry Agodoa; Andrzej Wiecek; Sarah Lewington; Christina A Reith; Martin J Landray; Colin Baigent
Journal:  Hypertension       Date:  2016-12-27       Impact factor: 10.190

9.  Respiratory parameters and acute kidney injury in acute respiratory distress syndrome: a causal inference study.

Authors:  Tacyano Tavares Leite; Cícero Abdon Malheiro Gomes; Juan Miguel Cosquillo Valdivia; Alexandre Braga Libório
Journal:  Ann Transl Med       Date:  2019-12

10.  Smoking habit as a risk amplifier in chronic kidney disease patients.

Authors:  Michele Provenzano; Raffaele Serra; Ashour Michael; Davide Bolignano; Giuseppe Coppolino; Nicola Ielapi; Giuseppe Filiberto Serraino; Pasquale Mastroroberto; Francesco Locatelli; Luca De Nicola; Michele Andreucci
Journal:  Sci Rep       Date:  2021-07-20       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.